Lossos C, Brown J, Sheikhbahaei S, et al. Idiopathic multicentric Castleman disease - TAFRO results in high levels of mTOR activator SVEP1, tissue factor, and endotheliopathy. Blood Vessels Thromb Hemost. 2024;1(2):100006.

On page 1, the following footnote should have been included: “As Editor-in-Chief of Blood Vessels, Thrombosis & Hemostasis, Keith R. McCrae recused himself from any involvement in the peer review of this article and had no access to information regarding its peer review. Full editorial responsibility for this article was delegated to Deputy Editor Karin Hoffmeister.”